The Food and Drug Administration's outside experts voted unanimously that Moderna's vaccine is safe and effective enough to give kids ages 6 to 17. If the FDA agrees, it would become the second option for those children, joining Pfizer's vaccine.
The Food and Drug Administration's outside experts voted unanimously that Moderna's vaccine is safe and effective enough to give kids ages 6 to 17. If the FDA agrees, it would become the second option for those children, joining Pfizer's vaccine.
The Massachusetts company is seeking clearance for two doses, and plans to later offer a booster. Tuesday's vote was only for two doses — full-strength for 12-17 and half-sized doses for those 6-11. In their review, FDA scientists said there were no confirmed cases of the heart inflammation in Moderna's kid studies. But experts say the studies may have had too few participants for a rare side effect like that to appear.
The FDA analysis concluded that two doses of Moderna are effective in preventing symptomatic COVID-19 illness in teens and younger kids, with the levels of virus-fighting antibodies comparable to those developed in young adults.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
FDA says Pfizer's COVID-19 vaccine appears effective for kids under 5Federal health officials said Sunday that kid-sizes doses of Pfizer’s COVID-19 vaccines appear to be safe and effective for kids under 5. If regulators clear the shots, vaccinations could begin as soon as next week.
Baca lebih lajut »
FDA: Pfizer COVID-19 Shot Appears Effective For Kids Under 5The review by federal health officials was a key step toward a long-awaited decision to begin vaccinating the youngest American children.
Baca lebih lajut »
FDA says Pfizer COVID-19 vaccine appears effective for children under 5The FDA said Pfizer's coronavirus vaccine appears to be safe for children younger than 5, the only age group not yet eligible for vaccination in the U.S.
Baca lebih lajut »
FDA advisers to weigh expanding Covid-19 vaccines to younger childrenSeveral months after older children became eligible to get vaccinated against Covid-19, the United States might be just days away from offering vaccines to those younger than 5.
Baca lebih lajut »
FDA Advisers Considering Moderna’s Covid-19 Vaccine for Ages 6 to 17An advisory committee is set to vote Tuesday on whether to recommend that the Food and Drug Administration authorize use of the Moderna vaccine for 6- to 17-year-olds.
Baca lebih lajut »
FDA Advisers Back Moderna's COVID-19 Vaccine for Older KidsA government advisory panel Tuesday endorsed a second brand of COVID-19 vaccine for school-age children and teens. The Food and Drug Administration’s outside experts voted unanimously that Moderna’s vaccine is safe and effective enough to give kids ages 6 to 17. If the FDA agrees, it would become the second option for those children, joining Pfizer’s vaccine. The same FDA…
Baca lebih lajut »